ASCLETIS PHARMA INC financial statements, including revenue, expenses, profit, and loss
The total revenue of 1672 for the last semiannual is 10.90 M HKD, and it's 79.27% lower compared to the previous semiannual. The net income of H2 23 is -138.45 M HKD.